Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo.

Hu X, Majchrzak K, Liu X, Wyatt MM, Spooner CJ, Moisan J, Zou W, Carter LL, Paulos CM.

Cancer Res. 2018 Jul 15;78(14):3888-3898. doi: 10.1158/0008-5472.CAN-17-3973. Epub 2018 May 16.

PMID:
29769201
2.

Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity.

Hu X, Liu X, Moisan J, Wang Y, Lesch CA, Spooner C, Morgan RW, Zawidzka EM, Mertz D, Bousley D, Majchrzak K, Kryczek I, Taylor C, Van Huis C, Skalitzky D, Hurd A, Aicher TD, Toogood PL, Glick GD, Paulos CM, Zou W, Carter LL.

Oncoimmunology. 2016 Nov 4;5(12):e1254854. doi: 10.1080/2162402X.2016.1254854. eCollection 2016.

3.

Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity.

Guo Y, MacIsaac KD, Chen Y, Miller RJ, Jain R, Joyce-Shaikh B, Ferguson H, Wang IM, Cristescu R, Mudgett J, Engstrom L, Piers KJ, Baltus GA, Barr K, Zhang H, Mehmet H, Hegde LG, Hu X, Carter LL, Aicher TD, Glick G, Zaller D, Hawwari A, Correll CC, Jones DC, Cua DJ.

Cell Rep. 2016 Dec 20;17(12):3206-3218. doi: 10.1016/j.celrep.2016.11.073.

4.

Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.

Sissoko D, Duraffour S, Kerber R, Kolie JS, Beavogui AH, Camara AM, Colin G, Rieger T, Oestereich L, Pályi B, Wurr S, Guedj J, Nguyen THT, Eggo RM, Watson CH, Edmunds WJ, Bore JA, Koundouno FR, Cabeza-Cabrerizo M, Carter LL, Kafetzopoulou LE, Kuisma E, Michel J, Patrono LV, Rickett NY, Singethan K, Rudolf M, Lander A, Pallasch E, Bockholt S, Rodríguez E, Di Caro A, Wölfel R, Gabriel M, Gurry C, Formenty P, Keïta S, Malvy D, Carroll MW, Anglaret X, Günther S.

Lancet Glob Health. 2017 Jan;5(1):e80-e88. doi: 10.1016/S2214-109X(16)30243-1.

5.

Real-time, portable genome sequencing for Ebola surveillance.

Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, Bore JA, Koundouno R, Dudas G, Mikhail A, Ouédraogo N, Afrough B, Bah A, Baum JH, Becker-Ziaja B, Boettcher JP, Cabeza-Cabrerizo M, Camino-Sanchez A, Carter LL, Doerrbecker J, Enkirch T, Dorival IGG, Hetzelt N, Hinzmann J, Holm T, Kafetzopoulou LE, Koropogui M, Kosgey A, Kuisma E, Logue CH, Mazzarelli A, Meisel S, Mertens M, Michel J, Ngabo D, Nitzsche K, Pallash E, Patrono LV, Portmann J, Repits JG, Rickett NY, Sachse A, Singethan K, Vitoriano I, Yemanaberhan RL, Zekeng EG, Trina R, Bello A, Sall AA, Faye O, Faye O, Magassouba N, Williams CV, Amburgey V, Winona L, Davis E, Gerlach J, Washington F, Monteil V, Jourdain M, Bererd M, Camara A, Somlare H, Camara A, Gerard M, Bado G, Baillet B, Delaune D, Nebie KY, Diarra A, Savane Y, Pallawo RB, Gutierrez GJ, Milhano N, Roger I, Williams CJ, Yattara F, Lewandowski K, Taylor J, Rachwal P, Turner D, Pollakis G, Hiscox JA, Matthews DA, O'Shea MK, Johnston AM, Wilson D, Hutley E, Smit E, Di Caro A, Woelfel R, Stoecker K, Fleischmann E, Gabriel M, Weller SA, Koivogui L, Diallo B, Keita S, Rambaut A, Formenty P, Gunther S, Carroll MW.

Nature. 2016 Feb 11;530(7589):228-232. doi: 10.1038/nature16996. Epub 2016 Feb 3.

6.

Corrigendum: Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists.

Hu X, Wang Y, Hao LY, Liu X, Lesch CA, Sanchez BM, Wendling JM, Morgan RW, Aicher TD, Carter LL, Toogood PL, Glick GD.

Nat Chem Biol. 2015 Sep;11(9):741. doi: 10.1038/nchembio0915-741b. No abstract available.

PMID:
26284677
7.

Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists.

Hu X, Wang Y, Hao LY, Liu X, Lesch CA, Sanchez BM, Wendling JM, Morgan RW, Aicher TD, Carter LL, Toogood PL, Glick GD.

Nat Chem Biol. 2015 Feb;11(2):141-7. doi: 10.1038/nchembio.1714. Epub 2015 Jan 5. Erratum in: Nat Chem Biol. 2015 Sep;11(9):741.

PMID:
25558972
8.

Population structure of and mycotoxin production by Fusarium graminearum from maize in South Korea.

Lee J, Kim H, Jeon JJ, Kim HS, Zeller KA, Carter LL, Leslie JF, Lee YW.

Appl Environ Microbiol. 2012 Apr;78(7):2161-7. doi: 10.1128/AEM.07043-11. Epub 2012 Jan 27.

9.

The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease.

Jackson LJ, Pheneger JA, Pheneger TJ, Davis G, Wright AD, Robinson JE, Allen S, Munson MC, Carter LL.

Cell Immunol. 2012;272(2):200-13. doi: 10.1016/j.cellimm.2011.10.011. Epub 2011 Oct 25.

PMID:
22078270
10.

Population structure of Fusarium fujikuroi from California rice and water grass.

Carter LL, Leslie JF, Webster RK.

Phytopathology. 2008 Sep;98(9):992-8. doi: 10.1094/PHYTO-98-9-0992.

11.

Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.

Bedard PW, Clerin V, Sushkova N, Tchernychev B, Antrilli T, Resmini C, Keith JC Jr, Hennan JK, Kaila N, Debernardo S, Janz K, Wang Q, Crandall DL, Schaub RG, Shaw GD, Carter LL.

J Pharmacol Exp Ther. 2008 Feb;324(2):497-506. Epub 2007 Nov 16.

12.

PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.

Carter LL, Leach MW, Azoitei ML, Cui J, Pelker JW, Jussif J, Benoit S, Ireland G, Luxenberg D, Askew GR, Milarski KL, Groves C, Brown T, Carito BA, Percival K, Carreno BM, Collins M, Marusic S.

J Neuroimmunol. 2007 Jan;182(1-2):124-34. Epub 2006 Dec 19.

PMID:
17182110
13.

Therapeutic opportunities in the B7/CD28 family of ligands and receptors.

Carreno BM, Carter LL, Collins M.

Curr Opin Pharmacol. 2005 Aug;5(4):424-30. Review.

PMID:
15935730
14.

PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.

Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA, Wooters J, Qiu Y, Jussif JM, Carter LL, Wood CR, Chaudhary D.

FEBS Lett. 2004 Sep 10;574(1-3):37-41.

15.
16.

IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity.

Kasaian MT, Whitters MJ, Carter LL, Lowe LD, Jussif JM, Deng B, Johnson KA, Witek JS, Senices M, Konz RF, Wurster AL, Donaldson DD, Collins M, Young DA, Grusby MJ.

Immunity. 2002 Apr;16(4):559-69.

17.

Efficacy of an amitraz-impregnated collar in preventing transmission of Borrelia burgdorferi by adult Ixodes scapularis to dogs.

Elfassy OJ, Goodman FW, Levy SA, Carter LL.

J Am Vet Med Assoc. 2001 Jul 15;219(2):185-9.

PMID:
11469572
18.

PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ.

Nat Immunol. 2001 Mar;2(3):261-8.

PMID:
11224527
19.

Present and future capabilities of MCNP

Hendricks JS, Adam KJ, Booth TE, Briesmeister JF, Carter LL, Cox LJ, Favorite JA, Forster RA, McKinney GW, Prael RE.

Appl Radiat Isot. 2000 Oct;53(4-5):857-61.

PMID:
11003531
21.

From naive to memory. Development and regulation of CD4+ T cell responses.

Carter LL, Swain SL.

Immunol Res. 1998 Aug;18(1):1-13.

PMID:
9724845
22.

In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines.

Cerwenka A, Carter LL, Reome JB, Swain SL, Dutton RW.

J Immunol. 1998 Jul 1;161(1):97-105.

23.

Regulation of T cell subsets from naive to memory.

Carter LL, Zhang X, Dubey C, Rogers P, Tsui L, Swain SL.

J Immunother. 1998 May;21(3):181-7. Review.

PMID:
9610909
24.

Single cell analyses of cytokine production.

Carter LL, Swain SL.

Curr Opin Immunol. 1997 Apr;9(2):177-82. Review.

PMID:
9099799
25.

Type 1 and type 2: a fundamental dichotomy for all T-cell subsets.

Carter LL, Dutton RW.

Curr Opin Immunol. 1996 Jun;8(3):336-42. Review.

PMID:
8793995
26.

Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations.

Carter LL, Dutton RW.

J Immunol. 1995 Aug 1;155(3):1028-31.

PMID:
7543509
27.

Multiple GTP-binding proteins participate in clathrin-coated vesicle-mediated endocytosis.

Carter LL, Redelmeier TE, Woollenweber LA, Schmid SL.

J Cell Biol. 1993 Jan;120(1):37-45.

28.

Cytosol- and clathrin-dependent stimulation of endocytosis in vitro by purified adaptors.

Smythe E, Carter LL, Schmid SL.

J Cell Biol. 1992 Dec;119(5):1163-71.

29.

ATP is required for receptor-mediated endocytosis in intact cells.

Schmid SL, Carter LL.

J Cell Biol. 1990 Dec;111(6 Pt 1):2307-18.

Supplemental Content

Loading ...
Support Center